The Science

Biomedical Reality

ME is a multi-system disease with documented abnormalities across energy metabolism, autonomic function, immune regulation, and neurological systems.

The biomedical reality of ME is no longer in question. Decades of research have documented objective abnormalities that distinguish ME patients from both healthy controls and patients with other fatiguing conditions.

These findings are reproducible, measurable, and consistent with patient-reported symptoms. They demonstrate that ME is a physiological disease — not a psychological condition, not a lifestyle issue, and not a matter of deconditioning or illness beliefs.

Energy Metabolism

Cellular energy production is fundamentally impaired.

Mitochondrial dysfunction affects ATP production at the cellular level. Oxygen utilisation is impaired, and metabolic responses to exertion are abnormal. Two-day cardiopulmonary exercise testing reveals objective decline in ME patients where healthy controls improve.

The energy envelope — the total amount of energy available for daily activities — is significantly reduced from normal baseline. This is not perception. This is measurable physiology.

Autonomic Nervous System

The body's automatic regulatory systems malfunction.

Orthostatic intolerance — difficulty maintaining upright posture — is common. Heart rate and blood pressure dysregulation occurs. Temperature regulation is abnormal. The digestive system malfunctions. Sleep architecture is disrupted despite profound exhaustion.

These are not stress responses. These are documented dysfunctions of the systems that regulate basic bodily functions.

Immune System

Chronic immune activation and dysfunction.

Elevated inflammatory markers are found in subsets of patients. Natural killer cell function is consistently impaired. Cytokine abnormalities suggest chronic immune activation, particularly in the early years of illness. Susceptibility to infections is increased. Autoimmune features appear in some patients.

Neurological Function

Brain and nervous system involvement.

Neuroinflammation has been demonstrated on PET imaging. Cognitive impairment affects memory, concentration, and processing speed. Sensory sensitivities to light, sound, and touch are common. Brain connectivity patterns are altered. Cerebral blood flow is reduced.

Post-Exertional Malaise

The hallmark feature that distinguishes ME from other conditions.

Post-exertional malaise (PEM) is characterised by delayed onset — symptoms typically worsen 12–72 hours after exertion, not immediately. The response is disproportionate: minimal activity can trigger severe symptom exacerbation. Recovery is prolonged: days, weeks, or in cases of severe overexertion, permanent decline.

PEM affects cognitive function, pain levels, autonomic symptoms, and overall functioning — not just fatigue. The existence and characteristics of PEM have been confirmed through objective testing, including two-day cardiopulmonary exercise testing.

PEM is not normal fatigue.
It is not muscle soreness.
It is a pathological response indicating that exertion has caused physiological harm.

Key Research Findings

Two-Day CPET

Cardiopulmonary exercise testing on consecutive days shows objective, measurable decline in ME patients where healthy controls improve. This is the gold standard for demonstrating post-exertional malaise.

Metabolomics

Studies reveal distinct metabolic signatures in ME patients, with abnormalities in energy pathways, amino acid metabolism, and lipid profiles.

Neuroimaging

PET scans have demonstrated neuroinflammation in ME patients. MRI studies show altered brain connectivity and reduced grey matter volume in specific regions.

Immune Profiling

Natural killer cell function is consistently impaired. Cytokine patterns suggest ongoing immune activation, particularly in the early years of illness.

Why this matters

The biomedical evidence has direct implications for treatment and care.

Treatments that push patients to increase activity are not just ineffective — they cause measurable harm. Pacing and energy management are not “giving in” to illness — they are medically appropriate responses to a physiological limitation.

Research into underlying mechanisms offers the possibility of targeted treatments in future. Clinical education must be updated to reflect this reality, replacing outdated psychological models.

The science is clear. The challenge now is ensuring that healthcare systems, welfare assessments, and public understanding catch up with the evidence.

This understanding aligns with current clinical guidance, including NICE NG206 (2021), and is increasingly supported by emerging biomedical research, including large-scale studies such as DecodeME.